-
SIGA Technologies, Inc. (SIGA) Reports Q4 EPS of $0.63
-
After-hours movers: GM, Stitch Fix, Dave & Buster's, GME and more
-
SIGA Technologies (SIGA): Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
-
SIGA Technologies, Inc. (SIGA) Reports Q3 EPS of $0.02
-
SIGA Technologies (SIGA) Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
-
SIGA Technologies (SIGA) Announces Agreement to Supply TPOXX in Morocco
-
SIGA Technologies (SIGA) terminates Chief Medical Officer
-
SIGA Technologies (SIGA) call put ratio 1.6 calls to 1 put on 2700 contracts
-
After-hours movers: Snowflake, Zoom, Zuora
-
SIGA Technologies (SIGA) Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX
-
SIGA Technologies (SIGA) call put ratio 5.8 calls to 1 put amid price movement
-
Mpox-linked stocks extend rally into second week
-
SIGA Technologies (SIGA) call put ratio 3.7 calls to 1 put with focus on September 15 and 20 calls
-
Increasing unusual option volume: SIGA HRB SGMO RKLB ITUB DDD EBS CRS
-
SIGA Technologies (SIGA) to Resume Trading at 8:05 am
-
SIGA Technologies' (SIGA) Tecovirimat in Treatment of Mpox Did Not Meet its Primary Endpoint
-
SIGA Technologies (SIGA) Halted, News Pending
-
Increasing unusual option volume: ROIV SIGA K ENB LUMN GRAB GFI CRMD BBD NICE EAT ACI
-
World Health Organization Declares monkeypox International Emergency
-
SIGA Technologies, Inc. (SIGA) Reports Q2 EPS of $0.03
-
SIGA Technologies (SIGA) Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX

